Theravance Biopharma Inc (TBPH) — Cash Flow Reinvestment Rate
Theravance Biopharma Inc (TBPH) has a Cash Flow Reinvestment Rate of 0.17x as of June 2025, reinvesting $36.29 Million (capex $34.00K plus investments $-36.26 Million) from operating cash flow of $208.07 Million. Explore TBPH capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Theravance Biopharma Inc Cash Flow Reinvestment Rate (2025–2025)
Historical reinvestment intensity for Theravance Biopharma Inc across 1 annual periods. Also explore how large is Theravance Biopharma Inc's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Theravance Biopharma Inc (2025–2025)
Year-by-year capital reinvestment analysis for Theravance Biopharma Inc. For live market cap and broader valuation context, see TBPH market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.44x | $105.28 Million | $238.54 Million | $42.00K | — |